(Q34727190)

4 August 2017

1 reference

title

Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence (English)

1 reference

4 August 2017

cardiovascular disease

1 reference

1

Frank B Hu

1 reference

4 August 2017

2

Francine Grodstein

1 reference

PubMed ID

12106637

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

American Journal of Cardiology

4 August 2017

1 reference

4 August 2017

90

1 reference

4 August 2017

1A

1 reference

4 August 2017

26F-29F

1 reference

Hormone replacement therapy, heart disease, and other considerations

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Hormone therapy to prevent disease and prolong life in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Hormone replacement therapy and risk of non-fatal stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Prospective study of exogenous hormones and risk of pulmonary embolism in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Risk of venous thromboembolism in users of hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

Primary prevention of coronary heart disease in women through diet and lifestyle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902219-6

10.1016/S0002-9149(01)02219-6

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12106637